NAUT Logo

Nautilus Biotechnology, Inc. (NAUT) 

NASDAQ
Market Cap
$352.21M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
222 of 776
Rank in Industry
128 of 433

Largest Insider Buys in Sector

NAUT Stock Price History Chart

NAUT Stock Performance

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Insider Activity of Nautilus Biotechnology, Inc.

Over the last 12 months, insiders at Nautilus Biotechnology, Inc. have bought $140,532 and sold $234,613 worth of Nautilus Biotechnology, Inc. stock.

On average, over the past 5 years, insiders at Nautilus Biotechnology, Inc. have bought $21.5M and sold $234,613 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Patel Sujal M (CEO, President, and Secretary) — $140,532.

The last purchase of 12,044 shares for transaction amount of $34,216 was made by Patel Sujal M (CEO, President, and Secretary) on 2024‑03‑11.

List of Insider Buy and Sell Transactions, Nautilus Biotechnology, Inc.

2024-09-23SaleSenior VP, Operations
47,031
0.0386%
$2.87$134,744-1.43%
2024-09-17SaleSenior VP, Operations
35,000
0.0277%
$2.85$99,869-4.47%
2024-03-11PurchaseCEO, President, and Secretary
12,044
0.0113%
$2.84$34,216+9.96%
2024-03-08PurchaseCEO, President, and Secretary
2,430
0.0019%
$2.99$7,262-11.07%
2024-03-07PurchaseCEO, President, and Secretary
18,854
0.0145%
$2.89$54,424-10.47%
2024-03-06PurchaseCEO, President, and Secretary
9,267
0.0075%
$2.70$25,034-1.85%
2024-03-05PurchaseCEO, President, and Secretary
7,405
0.0059%
$2.65$19,597+1.72%
2022-09-27PurchaseSenior VP, Product Development
5,000
0.004%
$2.03$10,149+17.73%
2022-09-26PurchaseSenior VP, Product Development
10,000
0.0083%
$2.02$20,250+21.68%
2022-09-23PurchaseChief People Officer
30,000
0.0244%
$2.03$60,765+19.00%
2022-09-16PurchaseSenior VP, Product Development
35,000
0.0288%
$2.16$75,446+9.52%
2022-09-15PurchaseSenior VP, Product Development
40,000
0.0319%
$2.19$87,752+4.07%
2022-08-19PurchaseCFO and Treasurer
17,500
0.0146%
$2.30$40,2190.00%
2022-08-12PurchaseGeneral Counsel
2,500
0.002%
$2.85$7,125-23.53%
2022-08-05PurchaseCEO, President, and Secretary
41,654
0.0332%
$2.92$121,646-24.83%
2022-06-27PurchaseCFO and Treasurer
5,500
0.0044%
$2.75$15,124-20.22%
2022-05-09PurchaseCEO, President, and Secretary
50,000
0.0447%
$3.96$198,000-37.92%
2022-03-03PurchaseCEO, President, and Secretary
50,000
0.0413%
$3.60$179,890-35.71%
2021-12-08Purchasedirector
200,000
0.2346%
$5.36$1.07M-41.22%
2021-12-01PurchaseCEO, President, and Secretary
88,022
0.1108%
$4.73$416,397-22.47%

Insider Historical Profitability

<0.0001%
Patel Sujal MCEO, President, and Secretary
10064488
8.0154%
$2.81100<0.0001%
PERCEPTIVE ADVISORS LLCdirector
9111151
7.2562%
$2.8150<0.0001%
McIlwain Matthew Sdirector
459075
0.3656%
$2.8140<0.0001%
Sankar SubramanianSenior VP, Product Development
91250
0.0727%
$2.8140+13.25%
Mowry AnnaCFO and Treasurer
56750
0.0452%
$2.8140<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Perceptive Advisors$37.03M10.0512.59M0%+$00.02
Cercano Management Llc$21.09M5.737.17M0%+$00.59
Madrona Venture Group$17.7M4.816.02M0%+$015.07
BlackRock$10.97M2.983.73M-4.16%-$475,788.99<0.0001
The Vanguard Group$8.41M2.282.86M+1.05%+$87,035.76<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.